A Pilot Investigation Detecting Cryoablation Scar by 3D Late Gadolinium Enhancement
LAMDE
1 other identifier
interventional
10
1 country
1
Brief Summary
This is a prospective trial investigating the effectiveness of a modified MRI preparatory pulse sequence to improve pulmonary vein isolation visualization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4 atrial-fibrillation
Started Dec 2016
Shorter than P25 for phase_4 atrial-fibrillation
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 16, 2016
CompletedFirst Posted
Study publicly available on registry
August 23, 2016
CompletedStudy Start
First participant enrolled
December 13, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 6, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 27, 2018
CompletedJune 29, 2018
June 1, 2018
1.2 years
August 16, 2016
June 27, 2018
Conditions
Outcome Measures
Primary Outcomes (3)
Blood Pool Corrected Signal Intensity
Through study completion, an average of 1 year
Imaging Failure Rate
Through study completion, an average of 1 year
Extent of Detected LGE Signal Correlate to the Respiratory Navigator Scheme
Through study completion, an average of 1 year
Study Arms (1)
CMRI Pulse Sequence
EXPERIMENTALPatients will have late gadolinium cardiac magnetic resonance images of the individual pulmonary veins acquired with the standard and the cylindrical navigator preparatory pulse sequences for comparison.
Interventions
Eligibility Criteria
You may qualify if:
- Men or non-pregnant women
- A diagnosis of symptomatic paroxysmal or recently persistent atrial fibrillation with a documented successful cardioversion within 4 months of the procedure
- Documented treatment failure or intolerance of at least 1 anti-arrhythmic medication used to control atrial fibrillation.
You may not qualify if:
- Contraindication to MRI, such as implanted incompatible metal prosthesis, or subject size exceeds bore or table limits
- Allergy to gadolinium-based contrast agent
- Previous atrial fibrillation ablation
- Renal dysfunction (estimated GFR \<60 mL/min/1.73m2) within 6 months
- Unwilling to provide informed consent for this protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Saint Luke's Health System
Kansas City, Missouri, 64111, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 16, 2016
First Posted
August 23, 2016
Study Start
December 13, 2016
Primary Completion
March 6, 2018
Study Completion
April 27, 2018
Last Updated
June 29, 2018
Record last verified: 2018-06
Data Sharing
- IPD Sharing
- Will not share